Neogen | NEOG - Cash And Equivalent


Neogen reported $145.34M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agilent USD 1.79B 254M Sep/2025
Avanos Medical USD 70.5M 19.8M Sep/2025
Bio-Rad Laboratories USD 395.8M 26.5M Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Idexx Laboratories USD 208.17M 43.57M Sep/2025
Illumina USD 934M 179M Jun/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
Neogen USD 145.34M 6.46M Sep/2025
Quidel USD 98.1M 53.6M Sep/2025
STAAR Surgical USD 176.16M 9.02M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Zoetis USD 2.08B 649M Sep/2025